Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annemijn L Tops

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ear and Hearing|May 11, 2021
Personalizing Transient Noise Reduction Algorithm Settings for Cochlear Implant UsersH Christiaan Stronks, Annemijn L Tops, Phillipp Hehrmann, et al.
Familial Cancer|June 18, 2026
Determinants of the quality of life of patients with NF2-related schwannomatosis and validation of the Dutch NFTI-QOL questionnaireAnnemijn L Tops, Dorine Goemans, Emmelien Aten, et al.
Cancers|February 13, 2025
Efficacy and Toxicity of Bevacizumab in Children with NF2-Related Schwannomatosis: A Systematic ReviewAnnemijn L Tops, Josefine E Schopman, Radboud W Koot, et al.
BMJ Open|April 8, 2026
[<sup>89</sup>Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trialJules P J Douwes, Annemijn L Tops, Petra Dibbets-Schneider, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ear and Hearing|May 11, 2021
Personalizing Transient Noise Reduction Algorithm Settings for Cochlear Implant UsersH Christiaan Stronks, Annemijn L Tops, Phillipp Hehrmann, et al.
Familial Cancer|June 18, 2026
Determinants of the quality of life of patients with NF2-related schwannomatosis and validation of the Dutch NFTI-QOL questionnaireAnnemijn L Tops, Dorine Goemans, Emmelien Aten, et al.
Cancers|February 13, 2025
Efficacy and Toxicity of Bevacizumab in Children with NF2-Related Schwannomatosis: A Systematic ReviewAnnemijn L Tops, Josefine E Schopman, Radboud W Koot, et al.
BMJ Open|April 8, 2026
[<sup>89</sup>Zr]bevacizumab PET/CT imaging of vestibular schwannomas for the prediction of bevacizumab treatment effect in patients with symptomatic <i>NF2</i>-related schwannomatosis: a study protocol for a phase II single centre, prospective, feasibility trialJules P J Douwes, Annemijn L Tops, Petra Dibbets-Schneider, et al.
Pageof 1